You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 14, 2025

Drug Price Trends for DOXYCYCLINE


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for DOXYCYCLINE

Average Pharmacy Cost for DOXYCYCLINE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
DOXYCYCLINE HYCLATE 100 MG CAP 72578-0055-18 0.12629 EACH 2025-04-23
DOXYCYCLINE HYCLATE 100 MG CAP 72578-0055-05 0.12629 EACH 2025-04-23
DOXYCYCLINE HYCLATE 50 MG CAP 72578-0054-18 0.16620 EACH 2025-04-23
DOXYCYCLINE HYCLATE 100 MG TAB 72578-0001-18 0.12859 EACH 2025-04-23
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for DOXYCYCLINE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
DOXYCYCLINE MONOHYDRATE 50MG CAP Golden State Medical Supply, Inc. 51407-0678-01 100 50.70 0.50700 EACH 2023-06-15 - 2028-06-14 FSS
DOXYCYCLINE MONOHYDRATE 100MG CAP Golden State Medical Supply, Inc. 64380-0180-01 50 38.12 0.76240 EACH 2023-06-15 - 2028-06-14 FSS
DOXYCYCLINE HYCLATE 50MG CAP AvKare, LLC 53489-0118-02 50 29.36 0.58720 EACH 2023-06-15 - 2028-06-14 FSS
DOXYCYCLINE MONOHYDRATE 150MG CAP Golden State Medical Supply, Inc. 64380-0181-01 60 539.32 8.98867 EACH 2023-06-15 - 2028-06-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for Doxycycline

Introduction to Doxycycline

Doxycycline, particularly in its hyclate form, is a widely used antibiotic known for its broad-spectrum efficacy against various bacterial diseases. It is commonly prescribed for treating conditions such as acne, malaria, urinary tract infections, and respiratory diseases. Here’s a comprehensive analysis of the market and price projections for doxycycline.

Market Size and Growth

The global doxycycline hyclate market has been experiencing significant growth. As of 2023, the market size was valued at approximately USD 1.2 billion. It is projected to reach USD 1.8 billion by 2031, growing at a Compound Annual Growth Rate (CAGR) of 4.5% from 2024 to 2031[1][3].

Market Segmentation

The market is segmented based on several key factors:

Application

  • Antibiotics
  • Acne Treatment
  • Malaria Treatment
  • Veterinary Medicine

Product Form

  • Tablets
  • Capsules
  • Powder
  • Injection Formulations

Geographical Regions

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle-East and Africa

Each segment contributes to the overall growth and dynamics of the market[1].

Driving Factors

Several factors are driving the growth of the doxycycline hyclate market:

Broad-Spectrum Efficacy

Doxycycline's effectiveness against a wide range of bacterial diseases, including respiratory and urinary tract infections, makes it a preferred choice among healthcare professionals[1].

Rising Prevalence of Infectious Diseases

The increasing incidence of infectious disorders and the growing awareness of STDs are significant growth drivers. Additionally, the drug's role in treating acne and malaria further boosts demand[1].

Improvements in Pharmaceutical Formulations

Advancements in pharmaceutical formulations and increased accessibility in both developed and developing countries are also contributing to market growth[1].

Economic and Seasonal Factors

Economic stabilization in regions like China, improved business morale in Germany, and the onset of winter seasons that increase the prevalence of infections, all contribute to a robust demand for doxycycline hydrochloride. This demand is expected to sustain upward pressure on prices[2].

Price Projections

Current Trends

The prices of doxycycline hydrochloride are expected to rise globally, driven by a surge in demand from end-user industries and constrained supply availability. Seasonal factors, such as the onset of winter, which increases the prevalence of illnesses, are also contributing to this trend[2].

Historical Context

In the past, the retail price of doxycycline has seen significant fluctuations. For instance, between 2013 and 2015, the price per pill increased dramatically from about three cents to over $5, causing concerns among healthcare providers and patients. Although there have been indications of price stabilization, the market remains vulnerable to future shortages and price hikes[5].

Future Outlook

Given the strong market fundamentals, including robust demand from pharmaceutical and healthcare sectors, doxycycline hydrochloride prices are likely to remain elevated in the coming months. The holiday season and the need for proactive inventory building by buyers are expected to maintain a bullish trend for prices[2].

Market Challenges

Despite the positive growth outlook, there are several challenges that could impact the market:

Adverse Effects

Adverse effects related to doxycycline can hinder market growth. Patients and healthcare providers must be aware of potential side effects, which could lead to a preference for alternative treatments[4].

Alternative Treatments

The presence of alternative treatments is another factor that could slow market growth. However, government initiatives for regulatory approvals and awareness campaigns about bacterial infection treatment are expected to offer lucrative opportunities for market expansion[4].

Competitive Landscape

The doxycycline hyclate market is characterized by a competitive landscape with several key players. The market report provides detailed profiles of companies, their strategies, and the competitive scenario, which helps in understanding the market dynamics and potential opportunities for growth[1].

Market Trends

New Product Launches

The market is expected to flourish with new product launches, particularly innovative formulations that enhance the efficacy and safety of doxycycline. R&D activities aimed at improving the quality of the drug are also anticipated to boost market growth[4].

Government Initiatives

Government initiatives for regulatory approvals and spreading awareness about bacterial infection treatment are expected to offer significant opportunities for market expansion. These initiatives can help in increasing the adoption of doxycycline and other antibiotics, thereby driving market growth[4].

Regional Analysis

The market is geographically segmented into North America, Europe, Asia-Pacific, South America, and Middle-East and Africa. Each region has its own set of drivers and challenges that influence the market dynamics.

  • Asia-Pacific: This region is expected to see significant growth due to improvements in healthcare infrastructure and an increase in the need for efficient antibiotics.
  • North America and Europe: These regions are characterized by high awareness of STD treatment and a strong focus on antibiotic stewardship, which drives demand for doxycycline[1].

Key Takeaways

  • The global doxycycline hyclate market is projected to grow from USD 1.2 billion in 2023 to USD 1.8 billion by 2031.
  • The market is driven by the drug's broad-spectrum efficacy, rising prevalence of infectious diseases, and improvements in pharmaceutical formulations.
  • Price projections indicate a rise in doxycycline hydrochloride prices due to strong demand and constrained supply.
  • Adverse effects and the presence of alternative treatments are potential challenges.
  • Government initiatives and new product launches are expected to offer lucrative opportunities for market expansion.

FAQs

1. What is the current market size of the doxycycline hyclate market? The current market size of the doxycycline hyclate market was valued at approximately USD 1.2 billion in 2023[1][3].

2. What is the projected growth rate of the doxycycline hyclate market? The market is expected to grow at a CAGR of 4.5% from 2024 to 2031[1].

3. What are the primary drivers of the doxycycline hyclate market? The primary drivers include the drug's broad-spectrum efficacy, rising prevalence of infectious diseases, and improvements in pharmaceutical formulations[1].

4. Why are doxycycline hydrochloride prices expected to rise? Prices are expected to rise due to a surge in demand from end-user industries, constrained supply availability, and seasonal factors that increase the prevalence of illnesses[2].

5. What challenges could impact the growth of the doxycycline hyclate market? Adverse effects related to doxycycline and the presence of alternative treatments are potential challenges that could hinder market growth[4].

Sources

  1. Marketresearchintellect: Doxycycline Hyclate Market Size, Share & Growth [2024-2031]
  2. ChemAnalyst: Global Doxycycline Hydrochloride Prices to Rise in November Amid Strong Market Fundamentals
  3. Dataintelo: Global Doxycycline Hyclate Sales Market Research Report 2032
  4. Allied Market Research: Oral Doxycycline Hyclate Market Size | Industry Growth By, 2030
  5. Vineyard Gazette: Cost of Doxycycline Skyrockets
Last updated: 2024-12-31

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.